4 results
The primary objective is to show that eplerenone treatment reduces progression of disease in presymptomatic PLN R14del-carriers
To compare the effect of standard care (Docetaxel monotherapy) versus the combination of Docetaxel with Rhenium-188 HEDP for the treatment of patients with progressive castration resistant prostate carcinoma metastatic tot bone.
The aim of the study is to investigate the value of DCB treatment in the residual disease of the coronary artery after successful recanalization and stenting of the actual CTO body as compared with complete stenting in a randomized fashion.
The aim of the study is to investigate the value of DCB treatment of single de-novo coronary artery lesions in patients with stable coronary artery disease, as compared to treatment with DES in a randomized fashion.